iclaprim has been researched along with ofloxacin in 1 studies
| Studies (iclaprim) | Trials (iclaprim) | Recent Studies (post-2010) (iclaprim) | Studies (ofloxacin) | Trials (ofloxacin) | Recent Studies (post-2010) (ofloxacin) |
|---|---|---|---|---|---|
| 45 | 7 | 16 | 6,484 | 976 | 1,346 |
| Protein | Taxonomy | iclaprim (IC50) | ofloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit A | Escherichia coli K-12 | 1.5 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammerschlag, MR; Hawser, S; Islam, K; Kohlhoff, SA; Reznik, T; Roblin, PM | 1 |
1 other study(ies) available for iclaprim and ofloxacin
| Article | Year |
|---|---|
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Folic Acid Antagonists; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pyrimidines | 2004 |